Advertisement

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Amit Sanyal, MD: A Clinician’s Perspective

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement

Jun

16

Today In Oncology

Thyroid Cancer Reproductive Lifespan, Hormone Therapy Potentially Linked to Incidence

Two-Pronged Nudges Result in Timely Conversations Around Priorities of Cancer Care

Neoadjuvant Sacituzumab Govitecan in MIBC

MIBC Intravesical Recombinant BCG and Chemoimmunotherapy

Overall Survival Benefit With Ivonescimab Plus Chemotherapy in Advanced Squamous NSCLC

Advertisement

© 2026 HSP News Service, L.L.C.